Abstract
Medication-induced xerostomia and hyposalivation will increasingly become oral health issues for older and geriatric patients because of the likely high prevalence of medication intake and polypharmacy, with a complex negative impact on other symptoms such as dysphagia, caries incidence, malnutrition, and quality of life. All healthcare professionals are encouraged to investigate dry mouth symptoms among their patients, since diagnosis can easily be performed within daily clinical practice. This practical article also provides a review of available treatment options, which include medication changes towards products with fewer xerogenic side effects or dose reductions, if possible, as well as multidisciplinary, preventive care-oriented approaches that consider all influencing factors and treatment of the oral symptoms. In addition, several topical agents and saliva substitutes are discussed that may provide symptomatic relief but need to be carefully adapted to each patient’s situation in terms of usability and practicability and in the knowledge that therapeutic success varies with each individual. Innovative methods such as intraoral electrostimulation or topical application of anticholinesterase on the oral mucosa are also discussed. The most commonly prescribed pharmaceutical treatment options for dry mouth are pilocarpine (a parasympathomimetic agent with potent muscarinic, cholinergic salivation-stimulating properties) and cevimeline (a quinuclidine analogue with therapeutic and side effects similar to those of pilocarpine). These pharmaceutic treatment options are described in the context of older patients, where the highly prevalent cholinergic side effects, which include nausea, emesis, bronchoconstriction, among others, need to be thoroughly supervised by the healthcare professionals involved. Providing these therapeutic options to patients with medication-induced dry mouth will help improve their oral health and therefore maintain a better quality of life, general health, and well-being.
Similar content being viewed by others
References
Ezeh AC, Bongaarts J, Mberu B. Global population trends and policy options. Lancet. 2012;380(9837):142–8. https://doi.org/10.1016/S0140-6736(12)60696-5.
Villa A, Wolff A, Aframian D, Vissink A, Ekström J, Proctor G, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19(7):1563–80. https://doi.org/10.1007/s00784-015-1488-2.
Turner MD. Hyposalivation and xerostomia: etiology, complications, and medical management. Dent Clin N Am. 2016;60(2):435–43. https://doi.org/10.1016/j.cden.2015.11.003.
Potulska A, Friedman A. Controlling sialorrhoea: a review of available treatment options. Expert Opin Pharmacother. 2005;6(9):1551–4. https://doi.org/10.1517/14656566.6.9.1551.
Sreebny L. Saliva in health and disease: an appraisal and update. Int Dent J. 2000;50(3):140–61.
Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134(1):61–9 (quiz 118–119).
Watanabe S, Dawes C. The effects of different foods and concentrations of citric acid on the flow rate of whole saliva in man. Arch Oral Biol. 1988;33(1):1–5.
Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis. 2002;8(3):117–29.
Heintze U, Birkhed D, Bjorn H. Secretion rate and buffer effect of resting and stimulated whole saliva as a function of age and sex. Swed Dent J. 1983;7(6):227–38.
Dawes C. How much saliva is enough for avoidance of xerostomia? Caries Res. 2004;38(3):236–40. https://doi.org/10.1159/000077760.
van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011;15(2):185–92. https://doi.org/10.1007/s00784-010-0382-1.
Atkinson JC, Wu AJ. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994;125(4):409–16.
Fischer D, Ship JA. The effect of dehydration on parotid salivary gland function. Spec Care Dent. 1997;17(2):58–64.
Murray Thomson W, Chalmers JM, John Spencer A, Slade GD, Carter KD. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology. 2006;23(4):205–13. https://doi.org/10.1111/j.1741-2358.2006.00135.x.
Smidt D, Torpet LA, Nauntofte B, Heegaard KM, Pedersen AM. Associations between labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol. 2010;38(5):422–35. https://doi.org/10.1111/j.1600-0528.2010.00554.x.
Smidt D, Torpet LA, Nauntofte B, Heegaard KM, Pedersen AM. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol. 2011;39(3):276–88. https://doi.org/10.1111/j.1600-0528.2010.00588.x.
Liu B, Dion MR, Jurasic MM, Gibson G, Jones JA. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(1):52–60. https://doi.org/10.1016/j.oooo.2011.11.014.
Nederfors T, Isaksson R, Mornstad H, Dahlof C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population–relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol. 1997;25(3):211–6.
Villa A, Polimeni A, Strohmenger L, Cicciu D, Gherlone E, Abati S. Dental patients’ self-reports of xerostomia and associated risk factors. J Am Dent Assoc. 2011;142(7):811–6.
Gil-Montoya JA, Barrios R, Sanchez-Lara I, Carnero-Pardo C, Fornieles-Rubio F, Montes J, et al. Prevalence of drug-induced xerostomia in older adults with cognitive impairment or dementia: an observational study. Drugs Aging. 2016;33(8):611–8. https://doi.org/10.1007/s40266-016-0386-x.
Barbe AG, Heinzler A, Derman S, Hellmich M, Timmermann L, Noack MJ. Hyposalivation and xerostomia among Parkinson’s disease patients and its impact on quality of life. Oral Dis. 2017;23(4):464–70. https://doi.org/10.1111/odi.12622.
Habbab KM, Moles DR, Porter SR. Potential oral manifestations of cardiovascular drugs. Oral Dis. 2010;16(8):769–73. https://doi.org/10.1111/j.1601-0825.2010.01686.x.
Nonzee V, Manopatanakul S, Khovidhunkit SO. Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications. J Med Assoc Thai. 2012;95(1):96–104.
Hunter KD, Wilson WS. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol. 1995;40(11):983–9.
Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth. Gerodontology. 1986;5(2):75–99.
Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AM, Proctor G, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral medicine VI. Drugs R D. 2017;17(1):1–28. https://doi.org/10.1007/s40268-016-0153-9.
Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78. https://doi.org/10.1001/jama.2008.892.
Aliko A, Wolff A, Dawes C, Aframian D, Proctor G, Ekström J, et al. World workshop on oral medicine VI: clinical implications of medication-induced salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(2):185–206. https://doi.org/10.1016/j.oooo.2014.10.027.
Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J. 2011;56(3):290–5. https://doi.org/10.1111/j.1834-7819.2011.01347.x.
Kane RL, Shamliyan T, Talley K, Pacala J. The association between geriatric syndromes and survival. J Am Geriatr Soc. 2012;60(5):896–904. https://doi.org/10.1111/j.1532-5415.2012.03942.x.
van der Putten GJ, de Baat C, De Visschere L, Schols J. Poor oral health, a potential new geriatric syndrome. Gerodontology. 2014;31(Suppl 1):17–24. https://doi.org/10.1111/ger.12086.
Tonetti MS, Bottenberg P, Conrads G, Eickholz P, Heasman P, Huysmans MC, et al. Dental caries and periodontal diseases in the ageing population: call to action to protect and enhance oral health and well-being as an essential component of healthy ageing—consensus report of group 4 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017;44(Suppl 18):S135–44. https://doi.org/10.1111/jcpe.12681.
Murray Thomson W. Epidemiology of oral health conditions in older people. Gerodontology. 2014;31(Suppl 1):9–16. https://doi.org/10.1111/ger.12085.
Hayes M, Da Mata C, Cole M, McKenna G, Burke F, Allen PF. Risk indicators associated with root caries in independently living older adults. J Dent. 2016;51:8–14. https://doi.org/10.1016/j.jdent.2016.05.006.
Ikebe K, Matsuda K, Kagawa R, Enoki K, Yoshida M, Maeda Y, et al. Association of masticatory performance with age, gender, number of teeth, occlusal force and salivary flow in Japanese older adults: is ageing a risk factor for masticatory dysfunction? Arch Oral Biol. 2011;56(10):991–6. https://doi.org/10.1016/j.archoralbio.2011.03.019.
Semba RD, Blaum CS, Bartali B, Xue QL, Ricks MO, Guralnik JM, et al. Denture use, malnutrition, frailty, and mortality among older women living in the community. J Nutr Health Aging. 2006;10(2):161–7.
Hatch JP, Shinkai RS, Sakai S, Rugh JD, Paunovich ED. Determinants of masticatory performance in dentate adults. Arch Oral Biol. 2001;46(7):641–8.
N’Gom PI, Woda A. Influence of impaired mastication on nutrition. J Prosthet Dent. 2002;87(6):667–73.
Samnieng P, Ueno M, Shinada K, Zaitsu T, Wright FA, Kawaguchi Y. Association of hyposalivation with oral function, nutrition and oral health in community-dwelling elderly Thai. Community Dent Health. 2012;29(1):117–23.
Rogus-Pulia NM, Gangnon R, Kind A, Connor NP, Asthana S. A pilot study of perceived mouth dryness, perceived swallowing effort, and saliva substitute effects in healthy adults across the age range. Dysphagia. 2017. https://doi.org/10.1007/s00455-017-9846-7.
Brochier CW, Hugo FN, Rech RS, Baumgarten A, Hilgert JB. Influence of dental factors on oropharyngeal dysphagia among recipients of long-term care. Gerodontology. 2018. https://doi.org/10.1111/ger.12345.
Kikutani T, Yoshida M, Enoki H, Yamashita Y, Akifusa S, Shimazaki Y, et al. Relationship between nutrition status and dental occlusion in community-dwelling frail elderly people. Geriatr Gerontol Int. 2013;13(1):50–4. https://doi.org/10.1111/j.1447-0594.2012.00855.x.
van der Maarel-Wierink CD, Meijers JM, De Visschere LM, de Baat C, Halfens RJ, Schols JM. Subjective dysphagia in older care home residents: a cross-sectional, multi-centre point prevalence measurement. Int J Nurs Stud. 2014;51(6):875–81. https://doi.org/10.1016/j.ijnurstu.2013.10.016.
van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM, Schols JM, de Baat C. Meta-analysis of dysphagia and aspiration pneumonia in frail elders. J Dent Res. 2011;90(12):1398–404. https://doi.org/10.1177/0022034511422909.
Nadig SD, Ashwathappa DT, Manjunath M, Krishna S, Annaji AG, Shivaprakash PK. A relationship between salivary flow rates and Candida counts in patients with xerostomia. J Oral Maxillofac Pathol. 2017;21(2):316. https://doi.org/10.4103/jomfp.JOMFP_231_16.
Adachi M, Ishihara K, Abe S, Okuda K. Professional oral health care by dental hygienists reduced respiratory infections in elderly persons requiring nursing care. Int J Dent Hyg. 2007;5(2):69–74. https://doi.org/10.1111/j.1601-5037.2007.00233.x.
Pound MW, Drew RH, Perfect JR. Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia. Curr Opin Infect Dis. 2002;15(2):183–94.
Barbe AG, Deutscher DHC, Derman SHM, Hellmich M, Noack MJ. Subjective and objective halitosis among patients with Parkinson’s disease. Gerodontology. 2017. https://doi.org/10.1111/ger.12293.
Koshimune S, Awano S, Gohara K, Kurihara E, Ansai T, Takehara T. Low salivary flow and volatile sulfur compounds in mouth air. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(1):38–41. https://doi.org/10.1067/moe.2003.S1079210403001628.
Tod AM, Kennedy F, Stocks AJ, McDonnell A, Ramaswamy B, Wood B, et al. Good-quality social care for people with Parkinson’s disease: a qualitative study. BMJ Open. 2016;6(2):e006813. https://doi.org/10.1136/bmjopen-2014-006813.
Bergdahl M. Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol. 2000;28(1):59–66.
Pajukoski H, Meurman JH, Halonen P, Sulkava R. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(6):641–9.
Acharya S, Hagglin C, Jontell M, Wenneberg B, Ekström J, Carlen A. Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome. Oral Dis. 2018. https://doi.org/10.1111/odi.12918.
Hoffman HJ, Cruickshanks KJ, Davis B. Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci. 2009;1170:514–30. https://doi.org/10.1111/j.1749-6632.2009.04597.x.
Boyce JM, Shone GR. Effects of ageing on smell and taste. Postgrad Med J. 2006;82(966):239–41. https://doi.org/10.1136/pgmj.2005.039453.
Lovat LB. Age related changes in gut physiology and nutritional status. Gut. 1996;38(3):306–9.
Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB. Prevalence and risk factors of self-reported smell and taste alterations: results from the 2011–2012 US National Health and Nutrition Examination Survey (NHANES). Chem Senses. 2016;41(1):69–76. https://doi.org/10.1093/chemse/bjv057.
Mata CD, Allen F. Time for routine use of minimum intervention dentistry in the elderly population. Gerodontology. 2015;32(1):1–2. https://doi.org/10.1111/ger.12178.
Barbe AG, Bock N, Derman SH, Felsch M, Timmermann L, Noack MJ. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson’s disease patients. Gerodontology. 2017;34(1):135–43. https://doi.org/10.1111/ger.12237.
Nagler RM. Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology. 2004;5(4):223–33. https://doi.org/10.1023/B:BGEN.0000038023.36727.50.
Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115(4):581–4.
Thomson WM, van der Putten GJ, de Baat C, Ikebe K, Matsuda K, Enoki K, et al. Shortening the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):322–7. https://doi.org/10.1016/j.tripleo.2011.03.024.
Radfar L, Masood F. Review of sialadenosis for clinicians. J Okla Dent Assoc. 2013;104(5):32–3.
Osailan S, Pramanik R, Shirodaria S, Challacombe SJ, Proctor GB. Investigating the relationship between hyposalivation and mucosal wetness. Oral Dis. 2011;17(1):109–14. https://doi.org/10.1111/j.1601-0825.2010.01715.x.
Krief G, Deutsch O, Zaks B, Wong DT, Aframian DJ, Palmon A. Comparison of diverse affinity based high-abundance protein depletion strategies for improved bio-marker discovery in oral fluids. J Proteom. 2012;75(13):4165–75. https://doi.org/10.1016/j.jprot.2012.05.012.
Wu AJ, Ship JA. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases. Oral Surg Oral Med Oral Pathol. 1993;76(3):301–6.
Nederfors T. Xerostomia and hyposalivation. Adv Dent Res. 2000;14:48–56.
Sreebny LM, Valdini A. Xerostomia. A neglected symptom. Arch Intern Med. 1987;147(7):1333–7.
Kleiner SM. Water: an essential but overlooked nutrient. J Am Diet Assoc. 1999;99(2):200–6. https://doi.org/10.1016/S0002-8223(99)00048-6.
DGAZ. Gesund im Alter—auch im Mund; 2018. https://dgaz.org/2016-06-22-13-34-30/informationsmaterialien-pflege/gesund-im-mund-auch-im-alter. Accessed 24 Aug 2018.
Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract. 2010;64(3):404–7. https://doi.org/10.1111/j.1742-1241.2009.02132.x.
Jordan RA, Bodechtel C, Hertrampf K, Hoffmann T, Kocher T, Nitschke I, et al. The Fifth German Oral Health Study (Funfte Deutsche Mundgesundheitsstudie, DMS V)—rationale, design, and methods. BMC Oral Health. 2014;14:161. https://doi.org/10.1186/1472-6831-14-161.
Hahnel S, Behr M, Handel G, Burgers R. Saliva substitutes for the treatment of radiation-induced xerostomia—a review. Support Care Cancer. 2009;17(11):1331–43. https://doi.org/10.1007/s00520-009-0671-x.
Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011;12:CD008934. https://doi.org/10.1002/14651858.cd008934.pub2.
van der Reijden WA, Vissink A, Veerman EC, Amerongen AV. Treatment of oral dryness related complaints (xerostomia) in Sjogren’s syndrome. Ann Rheum Dis. 1999;58(8):465–74.
Barbe AG, Schmidt-Park Y, Hamacher S, Derman SH, Noack MJ. Efficacy of GUM(R) Hydral versus Biotene(R) Oralbalance mouthwashes plus gels on symptoms of medication-induced xerostomia: a randomized, double-blind, crossover study. Clin Oral Investig. 2017. https://doi.org/10.1007/s00784-017-2096-0.
Alajbeg I, Falcao DP, Tran SD, Martin-Granizo R, Lafaurie GI, Matranga D, et al. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(6):773–81. https://doi.org/10.1016/j.oooo.2012.01.012.
Strietzel FP, Lafaurie GI, Mendoza GR, Alajbeg I, Pejda S, Vuletic L, et al. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum. 2011;63(1):180–90. https://doi.org/10.1002/art.27766.
Khosravani N, Birkhed D, Ekström J. The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study. Eur J Oral Sci. 2009;117(3):209–17. https://doi.org/10.1111/j.1600-0722.2009.00632.x.
Iwabuchi Y, Katagiri M, Masuhara T. Salivary secretion and histopathological effects after single administration of the muscarinic agonist SNI-2011 in MRL/lpr mice. Arch Int Pharmacodyn Ther. 1994;328(3):315–25.
Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs. 1995;49(1):143–55.
Takakura AC, Moreira TS, Laitano SC, De Luca Junior LA, Renzi A, Menani JV. Central muscarinic receptors signal pilocarpine-induced salivation. J Dent Res. 2003;82(12):993–7. https://doi.org/10.1177/154405910308201211.
Schneyer CA, Hall HD. Autonomic pathways involved in a sympathetic-like action of pilocarpine on salivary composition. Proc Soc Exp Biol Med. 1966;121(1):96–100.
Braga MA, Tarzia O, Bergamaschi CC, Santos FA, Andrade ED, Groppo FC. Comparison of the effects of pilocarpine and cevimeline on salivary flow. Int J Dent Hyg. 2009;7(2):126–30. https://doi.org/10.1111/j.1601-5037.2008.00326.x.
Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for the preparation of this manuscript.
Conflict of interest
AG Barbe has no conflicts of interest.
Rights and permissions
About this article
Cite this article
Barbe, A.G. Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management. Drugs Aging 35, 877–885 (2018). https://doi.org/10.1007/s40266-018-0588-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-018-0588-5